The following is a list of "hot" genes: those that have been most frequently requested at the GeneCards home site since Jul 3 , 2011, sorted by frequency of access.

  1. BCL2 B-cell CLL/lymphoma 2
  2. ABCB4 ATP-binding cassette, sub-family B (MDR/TAP), member 4
  3. ACVR1B activin A receptor, type IB
  4. ADAM9 ADAM metallopeptidase domain 9
  5. AKT2 v-akt murine thymoma viral oncogene homolog 2
  6. ACHE acetylcholinesterase
  7. ACADM acyl-CoA dehydrogenase, C-4 to C-12 straight chain
  8. GSK3B glycogen synthase kinase 3 beta
  9. AKT1 v-akt murine thymoma viral oncogene homolog 1
  10. ACSS2 acyl-CoA synthetase short-chain family member 2
  11. ABCA1 ATP-binding cassette, sub-family A (ABC1), member 1
  12. ABCB5 ATP-binding cassette, sub-family B (MDR/TAP), member 5
  13. AGER advanced glycosylation end product-specific receptor
  14. ADD1 adducin 1 (alpha)
  15. CASP8 caspase 8, apoptosis-related cysteine peptidase
  16. CAMKK1 calcium/calmodulin-dependent protein kinase kinase 1, alpha
  17. TP53 tumor protein p53
  18. ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1
  19. PCCA propionyl CoA carboxylase, alpha polypeptide
  20. EGFR epidermal growth factor receptor
  21. MAPK1 mitogen-activated protein kinase 1
  22. TNF tumor necrosis factor
  23. BRCA1 breast cancer 1, early onset
  24. ERBB2 v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)
  25. AR androgen receptor
  26. IFNG interferon, gamma
  27. ACLY ATP citrate lyase
  28. ABL1 c-abl oncogene 1, non-receptor tyrosine kinase
  29. ACTA2 actin, alpha 2, smooth muscle, aorta
  30. CDK2 cyclin-dependent kinase 2
  31. EGF epidermal growth factor
  32. CASP3 caspase 3, apoptosis-related cysteine peptidase
  33. SRC v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)
  34. MYC v-myc myelocytomatosis viral oncogene homolog (avian)
  35. CTNNB1 catenin (cadherin-associated protein), beta 1, 88kDa
  36. IL6 interleukin 6 (interferon, beta 2)
  37. MMP9 matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)
  38. APP amyloid beta (A4) precursor protein
  39. VEGFA vascular endothelial growth factor A
  40. NFKB1 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
  41. GAPDH glyceraldehyde-3-phosphate dehydrogenase
  42. ACTB actin, beta
  43. TGFB1 transforming growth factor, beta 1
  44. MAPK3 mitogen-activated protein kinase 3
  45. AIFM3 apoptosis-inducing factor, mitochondrion-associated, 3
  46. MMP2 matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)
  47. ATM ataxia telangiectasia mutated
  48. MDM2 Mdm2 p53 binding protein homolog (mouse)
  49. ESR1 estrogen receptor 1
  50. CDKN2A cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)
  51. CCND1 cyclin D1
  52. IL1B interleukin 1, beta
  53. JAK2 Janus kinase 2
  54. APC adenomatous polyposis coli
  55. PTEN phosphatase and tensin homolog
  56. GRB2 growth factor receptor-bound protein 2
  57. JUN jun proto-oncogene
  58. CREBBP CREB binding protein
  59. IL8 interleukin 8
  60. STAT3 signal transducer and activator of transcription 3 (acute-phase response factor)
  61. HGF hepatocyte growth factor (hepapoietin A; scatter factor)
  62. BRAF v-raf murine sarcoma viral oncogene homolog B1
  63. KIT v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
  64. KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog
  65. HIF1A hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
  66. KDR kinase insert domain receptor (a type III receptor tyrosine kinase)
  67. CDH1 cadherin 1, type 1, E-cadherin (epithelial)
  68. HTT huntingtin
  69. CDKN1A cyclin-dependent kinase inhibitor 1A (p21, Cip1)
  70. EP300 E1A binding protein p300
  71. PCNA proliferating cell nuclear antigen
  72. TERT telomerase reverse transcriptase
  73. HRAS v-Ha-ras Harvey rat sarcoma viral oncogene homolog
  74. SOD1 superoxide dismutase 1, soluble
  75. BAX BCL2-associated X protein
  76. IRS1 insulin receptor substrate 1
  77. CRP C-reactive protein, pentraxin-related
  78. NR3C1 nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
  79. INS insulin
  80. PPARG peroxisome proliferator-activated receptor gamma
  81. CFTR cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
  82. IL10 interleukin 10
  83. CCL2 chemokine (C-C motif) ligand 2
  84. IL2 interleukin 2
  85. IGF1 insulin-like growth factor 1 (somatomedin C)
  86. UBC ubiquitin C
  87. RB1 retinoblastoma 1
  88. ANXA2 annexin A2
  89. FYN FYN oncogene related to SRC, FGR, YES
  90. CD44 CD44 molecule (Indian blood group)
  91. PTGS2 prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
  92. PARP1 poly (ADP-ribose) polymerase 1
  93. ACE angiotensin I converting enzyme (peptidyl-dipeptidase A) 1
  94. PRKCA protein kinase C, alpha
  95. CXCL12 chemokine (C-X-C motif) ligand 12
  96. FAS Fas (TNF receptor superfamily, member 6)
  97. SP1 Sp1 transcription factor
  98. SERPINE1 serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
  99. RET ret proto-oncogene
  100. PIK3R1 phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
  101. FOS FBJ murine osteosarcoma viral oncogene homolog
  102. RAF1 v-raf-1 murine leukemia viral oncogene homolog 1
  103. BMP4 bone morphogenetic protein 4
  104. CREB1 cAMP responsive element binding protein 1
  105. MMP1 matrix metallopeptidase 1 (interstitial collagenase)
  106. NTRK1 neurotrophic tyrosine kinase, receptor, type 1
  107. FGFR1 fibroblast growth factor receptor 1
  108. FGFR2 fibroblast growth factor receptor 2
  109. APOE apolipoprotein E
  110. RELA v-rel reticuloendotheliosis viral oncogene homolog A (avian)
  111. DNMT1 DNA (cytosine-5-)-methyltransferase 1
  112. STAT1 signal transducer and activator of transcription 1, 91kDa
  113. ICAM1 intercellular adhesion molecule 1
  114. MTHFR methylenetetrahydrofolate reductase (NAD(P)H)
  115. BDNF brain-derived neurotrophic factor
  116. BCR breakpoint cluster region
  117. FGG fibrinogen gamma chain
  118. MAPK14 mitogen-activated protein kinase 14
  119. MET met proto-oncogene (hepatocyte growth factor receptor)
  120. CD40LG CD40 ligand
  121. ADA adenosine deaminase
  122. CDK4 cyclin-dependent kinase 4
  123. RAC1 ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
  124. CXCR4 chemokine (C-X-C motif) receptor 4
  125. ALB albumin
  126. HSPD1 heat shock 60kDa protein 1 (chaperonin)
  127. BRCA2 breast cancer 2, early onset
  128. MBP myelin basic protein
  129. FN1 fibronectin 1
  130. HSP90AA1 heat shock protein 90kDa alpha (cytosolic), class A member 1
  131. CCR5 chemokine (C-C motif) receptor 5
  132. PARK2 parkinson protein 2, E3 ubiquitin protein ligase (parkin)
  133. CASP9 caspase 9, apoptosis-related cysteine peptidase
  134. LCK lymphocyte-specific protein tyrosine kinase
  135. ALK anaplastic lymphoma receptor tyrosine kinase
  136. GNAS GNAS complex locus
  137. TBP TATA box binding protein
  138. VDR vitamin D (1,25- dihydroxyvitamin D3) receptor
  139. FUS fused in sarcoma
  140. IL4 interleukin 4
  141. BTK Bruton agammaglobulinemia tyrosine kinase
  142. PIK3CA phosphoinositide-3-kinase, catalytic, alpha polypeptide
  143. FGF2 fibroblast growth factor 2 (basic)
  144. NF1 neurofibromin 1
  145. MLH1 mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli)
  146. LEP leptin
  147. CAV1 caveolin 1, caveolae protein, 22kDa
  148. ITGB1 integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
  149. APEX1 APEX nuclease (multifunctional DNA repair enzyme) 1
  150. CCL5 chemokine (C-C motif) ligand 5
  151. TUBA8 tubulin, alpha 8
  152. NFKBIA nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
  153. MMP3 matrix metallopeptidase 3 (stromelysin 1, progelatinase)
  154. IGF1R insulin-like growth factor 1 receptor
  155. CAT catalase
  156. NXN nucleoredoxin
  157. UBB ubiquitin B
  158. MAP2K1 mitogen-activated protein kinase kinase 1
  159. CD14 CD14 molecule
  160. HDAC1 histone deacetylase 1
  161. HSPA8 heat shock 70kDa protein 8
  162. IGF2 insulin-like growth factor 2 (somatomedin A)
  163. AURKA aurora kinase A
  164. EGR1 early growth response 1
  165. MTOR mechanistic target of rapamycin (serine/threonine kinase)
  166. ADIPOQ adiponectin, C1Q and collagen domain containing
  167. AHR aryl hydrocarbon receptor
  168. VIM vimentin
  169. CYCS cytochrome c, somatic
  170. FGFR3 fibroblast growth factor receptor 3
  171. PIK3CG phosphoinositide-3-kinase, catalytic, gamma polypeptide
  172. IKBKB inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
  173. MAPT microtubule-associated protein tau
  174. INSR insulin receptor
  175. ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
  176. ERBB4 v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian)
  177. MAPK8 mitogen-activated protein kinase 8
  178. DMD dystrophin
  179. BMP6 bone morphogenetic protein 6
  180. YWHAZ tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide
  181. ETFB electron-transfer-flavoprotein, beta polypeptide
  182. FLT1 fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor)
  183. CDK1 cyclin-dependent kinase 1
  184. AGT angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
  185. CD36 CD36 molecule (thrombospondin receptor)
  186. SIRT1 sirtuin 1
  187. PTK2 PTK2 protein tyrosine kinase 2
  188. CDC42 cell division cycle 42 (GTP binding protein, 25kDa)
  189. MLL myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila)
  190. GGH gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)
  191. BCL2L1 BCL2-like 1
  192. HSPA1A heat shock 70kDa protein 1A
  193. PTPRC protein tyrosine phosphatase, receptor type, C
  194. ARNT aryl hydrocarbon receptor nuclear translocator
  195. HBB hemoglobin, beta
  196. MYB v-myb myeloblastosis viral oncogene homolog (avian)
  197. SMAD3 SMAD family member 3
  198. CD4 CD4 molecule
  199. BACE1 beta-site APP-cleaving enzyme 1
  200. HSPA5 heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
  201. PLAT plasminogen activator, tissue
  202. EPO erythropoietin
  203. IL1A interleukin 1, alpha
  204. TGFBR2 transforming growth factor, beta receptor II (70/80kDa)
  205. FOXP2 forkhead box P2
  206. SPP1 secreted phosphoprotein 1
  207. RHOA ras homolog gene family, member A
  208. TUBE1 tubulin, epsilon 1
  209. G6PD glucose-6-phosphate dehydrogenase
  210. COL1A1 collagen, type I, alpha 1
  211. SOD2 superoxide dismutase 2, mitochondrial
  212. F8 coagulation factor VIII, procoagulant component
  213. CYP1A1 cytochrome P450, family 1, subfamily A, polypeptide 1
  214. BMP2 bone morphogenetic protein 2
  215. LYN v-yes-1 Yamaguchi sarcoma viral related oncogene homolog
  216. CHUK conserved helix-loop-helix ubiquitous kinase
  217. SMAD4 SMAD family member 4
  218. SOX2 SRY (sex determining region Y)-box 2
  219. CSK c-src tyrosine kinase
  220. TF transferrin
  221. SLC6A4 solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
  222. BIRC5 baculoviral IAP repeat containing 5
  223. CYP2D6 cytochrome P450, family 2, subfamily D, polypeptide 6
  224. NOS3 nitric oxide synthase 3 (endothelial cell)
  225. ITGB3 integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
  226. PTPN11 protein tyrosine phosphatase, non-receptor type 11
  227. EZH2 enhancer of zeste homolog 2 (Drosophila)
  228. NOTCH1 notch 1
  229. PRKACA protein kinase, cAMP-dependent, catalytic, alpha
  230. ALDH2 aldehyde dehydrogenase 2 family (mitochondrial)
  231. MSH2 mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli)
  232. PLK1 polo-like kinase 1
  233. CBL Cas-Br-M (murine) ecotropic retroviral transforming sequence
  234. CSNK2A1 casein kinase 2, alpha 1 polypeptide
  235. FUK fucokinase
  236. MGMT O-6-methylguanine-DNA methyltransferase
  237. SHC1 SHC (Src homology 2 domain containing) transforming protein 1
  238. WT1 Wilms tumor 1
  239. VHL von Hippel-Lindau tumor suppressor
  240. LPP LIM domain containing preferred translocation partner in lipoma
  241. MAPK10 mitogen-activated protein kinase 10
  242. EIF4E eukaryotic translation initiation factor 4E
  243. GBA glucosidase, beta, acid
  244. NRAS neuroblastoma RAS viral (v-ras) oncogene homolog
  245. TNFSF10 tumor necrosis factor (ligand) superfamily, member 10
  246. BAD BCL2-associated agonist of cell death
  247. MPO myeloperoxidase
  248. SELE selectin E
  249. RUNX1 runt-related transcription factor 1
  250. FASLG Fas ligand (TNF superfamily, member 6)
  251. TGFBR1 transforming growth factor, beta receptor 1
  252. COMT catechol-O-methyltransferase
  253. RORA RAR-related orphan receptor A
  254. POMC proopiomelanocortin
  255. TNFRSF1A tumor necrosis factor receptor superfamily, member 1A
  256. CSF2 colony stimulating factor 2 (granulocyte-macrophage)
  257. CDKN1B cyclin-dependent kinase inhibitor 1B (p27, Kip1)
  258. TRAF6 TNF receptor-associated factor 6
  259. GSTM1 glutathione S-transferase mu 1
  260. FLT3 fms-related tyrosine kinase 3
  261. PRKDC protein kinase, DNA-activated, catalytic polypeptide
  262. CSF3 colony stimulating factor 3 (granulocyte)
  263. NOS2 nitric oxide synthase 2, inducible
  264. PDGFB platelet-derived growth factor beta polypeptide
  265. ERBB3 v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)
  266. LRP1 low density lipoprotein receptor-related protein 1
  267. ATR ataxia telangiectasia and Rad3 related
  268. JUP junction plakoglobin
  269. BID BH3 interacting domain death agonist
  270. SMAD2 SMAD family member 2
  271. SLC2A1 solute carrier family 2 (facilitated glucose transporter), member 1
  272. DRD2 dopamine receptor D2
  273. HPRT1 hypoxanthine phosphoribosyltransferase 1
  274. CASP1 caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase)
  275. PAX6 paired box 6
  276. TFRC transferrin receptor (p90, CD71)
  277. CYP2E1 cytochrome P450, family 2, subfamily E, polypeptide 1
  278. KITLG KIT ligand
  279. IGFBP3 insulin-like growth factor binding protein 3
  280. CXCL10 chemokine (C-X-C motif) ligand 10
  281. POU5F1 POU class 5 homeobox 1
  282. SOX9 SRY (sex determining region Y)-box 9
  283. CDK5 cyclin-dependent kinase 5
  284. IL13 interleukin 13
  285. PRKCB protein kinase C, beta
  286. CYP3A4 cytochrome P450, family 3, subfamily A, polypeptide 4
  287. MKI67 antigen identified by monoclonal antibody Ki-67
  288. BCL2L11 BCL2-like 11 (apoptosis facilitator)
  289. SERPINA1 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
  290. OPRM1 opioid receptor, mu 1
  291. LMNA lamin A/C
  292. CCNB1 cyclin B1
  293. CEBPB CCAAT/enhancer binding protein (C/EBP), beta
  294. YWHAE tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide
  295. JAK1 Janus kinase 1
  296. GATA3 GATA binding protein 3
  297. CASR calcium-sensing receptor
  298. PAK1 p21 protein (Cdc42/Rac)-activated kinase 1
  299. ASNS asparagine synthetase (glutamine-hydrolyzing)
  300. RPS27A ribosomal protein S27a
  301. CYP19A1 cytochrome P450, family 19, subfamily A, polypeptide 1
  302. ABCG2 ATP-binding cassette, sub-family G (WHITE), member 2
  303. DICER1 dicer 1, ribonuclease type III
  304. VCAM1 vascular cell adhesion molecule 1
  305. TLR4 toll-like receptor 4
  306. MUC1 mucin 1, cell surface associated
  307. PRKCZ protein kinase C, zeta
  308. PGR progesterone receptor
  309. SMARCA4 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
  310. HTR2A 5-hydroxytryptamine (serotonin) receptor 2A
  311. ABCC1 ATP-binding cassette, sub-family C (CFTR/MRP), member 1
  312. LPL lipoprotein lipase
  313. CRH corticotropin releasing hormone
  314. ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
  315. EEF1A1 eukaryotic translation elongation factor 1 alpha 1
  316. GSTP1 glutathione S-transferase pi 1
  317. NRG1 neuregulin 1
  318. PSEN1 presenilin 1
  319. HLA-B major histocompatibility complex, class I, B
  320. MITF microphthalmia-associated transcription factor
  321. ACTA1 actin, alpha 1, skeletal muscle
  322. HDAC2 histone deacetylase 2
  323. PLAU plasminogen activator, urokinase
  324. POLR2A polymerase (RNA) II (DNA directed) polypeptide A, 220kDa
  325. PRL prolactin
  326. CHEK2 CHK2 checkpoint homolog (S. pombe)
  327. ETS1 v-ets erythroblastosis virus E26 oncogene homolog 1 (avian)
  328. IKBKG inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
  329. STK11 serine/threonine kinase 11
  330. F2 coagulation factor II (thrombin)
  331. E2F1 E2F transcription factor 1
  332. SNCA synuclein, alpha (non A4 component of amyloid precursor)
  333. ABCC2 ATP-binding cassette, sub-family C (CFTR/MRP), member 2
  334. RPS6KB1 ribosomal protein S6 kinase, 70kDa, polypeptide 1
  335. GATA1 GATA binding protein 1 (globin transcription factor 1)
  336. SELP selectin P (granule membrane protein 140kDa, antigen CD62)
  337. CACNA1A calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
  338. TIMP1 TIMP metallopeptidase inhibitor 1
  339. CHEK1 CHK1 checkpoint homolog (S. pombe)
  340. ACP1 acid phosphatase 1, soluble
  341. NCOR1 nuclear receptor corepressor 1
  342. FOXO1 forkhead box O1
  343. CCL4 chemokine (C-C motif) ligand 4
  344. BCL6 B-cell CLL/lymphoma 6
  345. NGFR nerve growth factor receptor
  346. CTSD cathepsin D
  347. AURKB aurora kinase B
  348. APOB apolipoprotein B (including Ag(x) antigen)
  349. NBN nibrin
  350. APOA1 apolipoprotein A-I
  351. ATP2A2 ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
  352. RAD51 RAD51 homolog (S. cerevisiae)
  353. GATA4 GATA binding protein 4
  354. MECP2 methyl CpG binding protein 2 (Rett syndrome)
  355. TCF7L2 transcription factor 7-like 2 (T-cell specific, HMG-box)
  356. TYMS thymidylate synthetase
  357. PCCB propionyl CoA carboxylase, beta polypeptide
  358. HLA-DRB1 major histocompatibility complex, class II, DR beta 1
  359. XDH xanthine dehydrogenase
  360. ADRB2 adrenergic, beta-2-, receptor, surface
  361. MAOA monoamine oxidase A
  362. FLNA filamin A, alpha
  363. POR P450 (cytochrome) oxidoreductase
  364. CYP2C19 cytochrome P450, family 2, subfamily C, polypeptide 19
  365. CYP1A2 cytochrome P450, family 1, subfamily A, polypeptide 2
  366. CSF1 colony stimulating factor 1 (macrophage)
  367. TCF3 transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47)
  368. TRAF2 TNF receptor-associated factor 2
  369. HMGB1 high mobility group box 1
  370. HNF4A hepatocyte nuclear factor 4, alpha
  371. PRNP prion protein
  372. CBS cystathionine-beta-synthase
  373. CD40 CD40 molecule, TNF receptor superfamily member 5
  374. AKT3 v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma)
  375. RARA retinoic acid receptor, alpha
  376. HDAC3 histone deacetylase 3
  377. NOS1 nitric oxide synthase 1 (neuronal)
  378. IL3 interleukin 3 (colony-stimulating factor, multiple)
  379. SRF serum response factor (c-fos serum response element-binding transcription factor)
  380. ZAP70 zeta-chain (TCR) associated protein kinase 70kDa
  381. XPC xeroderma pigmentosum, complementation group C
  382. PRKCG protein kinase C, gamma
  383. DPP4 dipeptidyl-peptidase 4
  384. SST somatostatin
  385. CDKN3 cyclin-dependent kinase inhibitor 3
  386. NPM1 nucleophosmin (nucleolar phosphoprotein B23, numatrin)
  387. CCL3 chemokine (C-C motif) ligand 3
  388. CALR calreticulin
  389. BMI1 BMI1 polycomb ring finger oncogene
  390. LDLR low density lipoprotein receptor
  391. ERCC1 excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)
  392. LOX lysyl oxidase
  393. PDGFRA platelet-derived growth factor receptor, alpha polypeptide
  394. ANPEP alanyl (membrane) aminopeptidase
  395. SHH sonic hedgehog
  396. YWHAB tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide
  397. GCK glucokinase (hexokinase 4)
  398. PPARGC1A peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
  399. FGR Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog
  400. HMGCR 3-hydroxy-3-methylglutaryl-CoA reductase
  401. FASN fatty acid synthase
  402. CACNA1C calcium channel, voltage-dependent, L type, alpha 1C subunit
  403. XIAP X-linked inhibitor of apoptosis
  404. FH fumarate hydratase
  405. UNG uracil-DNA glycosylase
  406. ILK integrin-linked kinase
  407. MMP14 matrix metallopeptidase 14 (membrane-inserted)
  408. SYK spleen tyrosine kinase
  409. IL2RA interleukin 2 receptor, alpha
  410. ACTG1 actin, gamma 1
  411. RAN RAN, member RAS oncogene family
  412. CD34 CD34 molecule
  413. BMP3 bone morphogenetic protein 3
  414. EWSR1 Ewing sarcoma breakpoint region 1
  415. EDN1 endothelin 1
  416. PDPK1 3-phosphoinositide dependent protein kinase-1
  417. ITGA4 integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
  418. GSR glutathione reductase
  419. TTN titin
  420. PDGFRB platelet-derived growth factor receptor, beta polypeptide
  421. FGF1 fibroblast growth factor 1 (acidic)
  422. KCNQ1 potassium voltage-gated channel, KQT-like subfamily, member 1
  423. RRBP1 ribosome binding protein 1 homolog 180kDa (dog)
  424. GATA2 GATA binding protein 2
  425. PML promyelocytic leukemia
  426. UBE3A ubiquitin protein ligase E3A
  427. FBN1 fibrillin 1
  428. CALM1 calmodulin 1 (phosphorylase kinase, delta)
  429. PPARA peroxisome proliferator-activated receptor alpha
  430. TP63 tumor protein p63
  431. ESR2 estrogen receptor 2 (ER beta)
  432. ARSA arylsulfatase A
  433. PKM2 pyruvate kinase, muscle
  434. DRD4 dopamine receptor D4
  435. NR4A1 nuclear receptor subfamily 4, group A, member 1
  436. NGF nerve growth factor (beta polypeptide)
  437. LIF leukemia inhibitory factor (cholinergic differentiation factor)
  438. ASS1 argininosuccinate synthase 1
  439. SPEN spen homolog, transcriptional regulator (Drosophila)
  440. SOS1 son of sevenless homolog 1 (Drosophila)
  441. YY1 YY1 transcription factor
  442. PDX1 pancreatic and duodenal homeobox 1
  443. CAMK2G calcium/calmodulin-dependent protein kinase II gamma
  444. PRKCD protein kinase C, delta
  445. PSEN2 presenilin 2 (Alzheimer disease 4)
  446. IL5 interleukin 5 (colony-stimulating factor, eosinophil)
  447. B2M beta-2-microglobulin
  448. VEGFC vascular endothelial growth factor C
  449. GPT glutamic-pyruvate transaminase (alanine aminotransferase)
  450. KLK3 kallikrein-related peptidase 3
  451. ID2 inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
  452. MCL1 myeloid cell leukemia sequence 1 (BCL2-related)
  453. MMP13 matrix metallopeptidase 13 (collagenase 3)
  454. CHAT choline O-acetyltransferase
  455. TNFRSF1B tumor necrosis factor receptor superfamily, member 1B
  456. MUSK muscle, skeletal, receptor tyrosine kinase
  457. TLR2 toll-like receptor 2
  458. GFAP glial fibrillary acidic protein
  459. CALCA calcitonin-related polypeptide alpha
  460. HSPG2 heparan sulfate proteoglycan 2
  461. FHIT fragile histidine triad gene
  462. IDH1 isocitrate dehydrogenase 1 (NADP+), soluble
  463. IL1RN interleukin 1 receptor antagonist
  464. ATP2B1 ATPase, Ca++ transporting, plasma membrane 1
  465. MAP3K7 mitogen-activated protein kinase kinase kinase 7
  466. CLU clusterin
  467. SRY sex determining region Y
  468. FLT4 fms-related tyrosine kinase 4
  469. CD19 CD19 molecule
  470. TUBB tubulin, beta
  471. PAPPA pregnancy-associated plasma protein A, pappalysin 1
  472. YWHAG tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide
  473. CRK v-crk sarcoma virus CT10 oncogene homolog (avian)
  474. SUMO1 SMT3 suppressor of mif two 3 homolog 1 (S. cerevisiae)
  475. KCNH2 potassium voltage-gated channel, subfamily H (eag-related), member 2
  476. CDK6 cyclin-dependent kinase 6
  477. TTR transthyretin
  478. CCND2 cyclin D2
  479. BLM Bloom syndrome, RecQ helicase-like
  480. XPA xeroderma pigmentosum, complementation group A
  481. MEN1 multiple endocrine neoplasia I
  482. GNAQ guanine nucleotide binding protein (G protein), q polypeptide
  483. F7 coagulation factor VII (serum prothrombin conversion accelerator)
  484. CD79A CD79a molecule, immunoglobulin-associated alpha
  485. ADM adrenomedullin
  486. ITGAM integrin, alpha M (complement component 3 receptor 3 subunit)
  487. ITGAV integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51)
  488. TEK TEK tyrosine kinase, endothelial
  489. AXIN1 axin 1
  490. ANG angiogenin, ribonuclease, RNase A family, 5
  491. MMP7 matrix metallopeptidase 7 (matrilysin, uterine)
  492. NLK nemo-like kinase
  493. HSPA4 heat shock 70kDa protein 4
  494. PTPN1 protein tyrosine phosphatase, non-receptor type 1
  495. ACTN4 actinin, alpha 4
  496. HSP90AB1 heat shock protein 90kDa alpha (cytosolic), class B member 1
  497. DHFR dihydrofolate reductase
  498. VTN vitronectin
  499. PIN1 peptidylprolyl cis/trans isomerase, NIMA-interacting 1
  500. STAT5A signal transducer and activator of transcription 5A


Developed at the Crown Human Genome Center, Department of Molecular Genetics, the Weizmann Institute of Science

Copyright © 1996-2012 , Weizmann Institute of Science. All Rights Reserved.
hostname: 356980-web2.xennexinc.com db genecards_307_90 index build: 90 solr: 1.4